Two Sigma Securities, LLC Infinity Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.16 - $0.74 $897 - $4,152	5,612 Added 28.01%	25,650 $4,000
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.21 $9,217 - $24,245	20,038 New	20,038 $11,000
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $21,256 - $38,398	-11,428 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $17,370 - $43,654	11,428 New	11,428 $39,000
Q3 2019 Nov 14, 2019	SELL	$1.03 - $1.75 $16,420 - $27,898	-15,942 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.43 - $1.87 $22,797 - $29,811	15,942 New	15,942 $29,000
Q1 2019 May 15, 2019	SELL	$1.18 - $1.91 $40,274 - $65,190	-34,131 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.01 - $2.78 $34,472 - $94,884	34,131 New	34,131 $40,000
Q4 2017 Feb 14, 2018	SELL	$1.22 - $3.73 $24,740 - $75,640	-20,279 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$0.94 - $1.35 $19,062 - $27,376	20,279	20,279 $27,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.